TBI— 510(k) K232669

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K232669 for TBI, Substantially Equivalent on 2023-09-29. Applicant: Abbott Laboratories. Device class: 2.

Clearance details

Applicant: Abbott Laboratories
Product code: Code QAT
Device class: Class 2
Regulation: 21 CFR 866.5830
Advisory panel: Immunology
Date received: 2023-09-01
Decision date: 2023-09-29
Decision: Substantially Equivalent
Clearance type: Special
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code QAT

K240279 — VIDAS TBI (GFAP, UCH-L1)2024-05-01
K234143 — i-STAT TBI Cartridge with the i-STAT Alinity System2024-03-27
K223602 — Traumatic brain injury (TBI) test2023-03-02
K201778 — i-STAT TBI Plasma cartridge with the i-STAT Alinity System2021-01-08
DEN170045 — Banyan BTI2018-02-14

More clearances from Abbott Laboratories

K252424 — Anti-HCV Next2026-04-28
K243500 — ARCHITECT iGentamicin2025-07-09
K243168 — Alinity i Rubella IgG2025-06-20
K243283 — Alinity h-series System2025-02-20
K233932 — Alinity i Toxo IgM2024-08-30

Data sourced from openFDA. This site is unofficial and independent of the FDA.